Answering the call to action: rapid implementation of an in-center hemodialysis SARS-CoV-2 vaccination program.

Gleeson, Sarah; Martin, Paul; Bedi, Rachna; Lynch, Kathleen; Willicombe, Michelle; Lightstone, Liz

Gleeson, Sarah; Martin, Paul; Bedi, Rachna; Lynch, Kathleen; Willicombe, Michelle; Lightstone, Liz.

Gleeson S; Imperial Renal and Transplant Centre, Imperial College Healthcare NHS Trust, London, UK.
Martin P; Imperial Renal and Transplant Centre, Imperial College Healthcare NHS Trust, London, UK.
Bedi R; Imperial Renal and Transplant Centre, Imperial College Healthcare NHS Trust, London, UK.
Lynch K; Imperial Renal and Transplant Centre, Imperial College Healthcare NHS Trust, London, UK.
Willicombe M; Imperial Renal and Transplant Centre, Imperial College Healthcare NHS Trust, London, UK; Department of Immunology and Inflammation, Imperial College, London, UK.
Lightstone L; Imperial Renal and Transplant Centre, Imperial College Healthcare NHS Trust, London, UK; Department of Immunology and Inflammation, Imperial College, London, UK. Electronic address: l.lightstone@imperial.ac.uk.

Kidney Int ; 99(5): 1238-1239, 2021 05.

Article in English | MEDLINE | ID: covidwho-1386156

Subject(s)

COVID-19; SARS-CoV-2; COVID-19 Vaccines; Humans; Renal Dialysis/adverse effects; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Kidney Int Year: 2021 Document Type: Article Affiliation country: J.KINT.2021.03.007

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google